CD276 and prostate carcinoma: In a recent study, treatment of fractionated irradiation significantly upregulates B7-H3 expression in prostate cancer cells, and is more effective in controlling xenograft growth in mice after B7-H3 CAR-T-cell administration than monotherapies (26).